Literature DB >> 22332773

Activation of ERK1/2-CREB pathway during potentiating synaptic transmission of (-)clausenamide in rat dentate gyrus.

Jin-Feng Hu1, Fei Niu, Na Ning, Wen-Zhen Duan, Shi-Feng Chu, Wei Xue, Yu-He Yuan, Nai-Hong Chen, Jun-Tian Zhang.   

Abstract

To investigate the signal mechanism of (-)clausenamide ((-)-3-hydroxy-5-(hydroxy-phenyl-methyl)-1-methyl-4-phenyl-pyrrolidin-2-one, 1) and for understanding its effect on synaptic transmission, electrophysiological recording was done for basal synaptic transmission determination. Western blot analysis was employed to examine the phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) and cAMP responsive element-binding protein (CREB). Immunohistochemistry and tissue in situ hybridization were applied to detect the expression of Zif268. The results showed that (-)clausenamide (1) increased the population spike of hippocampal dentate gyrus. The phosphorylation of ERK1/2 in hippocampus and cortex was increased and reached the maximum at 5 min and 30 min, respectively. (-)Clausenamide (1) promoted the phosphorylation of CREB, the downstream protein of ERK1/2. The expression of Zif268 protein and mRNA increased in both hippocampal dentate gyrus and cortex. Therefore, (-)clausenamide (1) activated the ERK1/2-CREB pathway, which may provide an explanation for its effect on potentiating synaptic transmission and improving learning and memory.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22332773     DOI: 10.1080/10286020.2011.650885

Source DB:  PubMed          Journal:  J Asian Nat Prod Res        ISSN: 1028-6020            Impact factor:   1.569


  3 in total

Review 1.  Overlapped metabolic and therapeutic links between Alzheimer and diabetes.

Authors:  Waqar Ahmad
Journal:  Mol Neurobiol       Date:  2012-09-26       Impact factor: 5.590

Review 2.  Exploiting Common Aspects of Obesity and Alzheimer's Disease.

Authors:  Sidra Tabassum; Afzal Misrani; Li Yang
Journal:  Front Hum Neurosci       Date:  2020-12-15       Impact factor: 3.169

Review 3.  Recent advances in the study of (-)clausenamide: chemistry, biological activities and mechanism of action.

Authors:  Shi-Feng Chu; Jun-Tian Zhang
Journal:  Acta Pharm Sin B       Date:  2014-11-20       Impact factor: 11.413

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.